Shop
eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
Alzheimer’s disease, Parkinson’s disease and other neurodegenerative conditions are typically seen – and treated – as distinct diseases with their own unique etiologies and targeted therapies. But a paper published recently in Translational Neurodegeneration outlines a new perspective, one that sees Alzheimer’s (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD) as different manifestations of related underlying bioenergetic abnormalities that all of these conditions appear to have in common.
Research suggests that the symptoms indicative of these conditions – cognitive impairment in AD, motor impairments in PD, for example – are late developments that occur far downstream of neuronal energy deficits that begin decades before diagnosis. All four conditions addressed in the paper are associated with alterations in mitochondrial structure and function and decreased neuronal ATP synthesis, which are hypothesized to begin long before the signature pathological features become evident.
The paper identifies numerous factors as potential contributors to the cellular dysfunction in these conditions, such as toxic environmental exposures (e.g., heavy metals, air pollution, pesticides), poor sleep, social isolation, physical inactivity, and the modern diet, with its preponderance of refined carbohydrates and multiple daily feeding opportunities with little to no periods of fasting or digestive rest.
Existing treatments for neurodegenerative disorders are associated with unwanted side-effects and may lose efficacy over time. Moreover, they are primarily aimed at symptom suppression and do little to address the underlying root causes because it’s not known for certain what the root causes are. But this paper is a step forward toward this end and presents a well-reasoned overview of what could potentially be contributing to these refractory conditions, how and why they are much more alike than is commonly acknowledged, their numerous shared molecular signatures, and what types of interventions may be more effective than current treatments are for restoring healthy neuronal function.
Submit this form and you'll receive our latest news and updates.
The journal Alzheimer’s & Dementia recently published results suggesting that urolithin A may have potential benefit...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment